Clinical Trial Update: Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial of a tumor-pulsed dendritic cell vaccine in metastatic colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tumor-pulsed dendritic cell vaccine (Dendritic cell vaccine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED